Generative AI Tools for Regulatory Writing
Regulatory writing is a crucial component of the drug development process. Regulatory writers must understand…
CertaraJune 20, 2024
RAPS Sponsored Webcast: Author Clinical Study Reports with Data Privacy & Disclosure in Mind
EMA Policy 0070 is a main driver for clinical trial data anonymization. This regulation requires…
CertaraJune 19, 2024
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies RADNOR, PA…
CertaraJune 17, 2024
Introducing CoAuthor™: The Gen-AI Enabled Solution for Regulatory Writers
Faced with more (and more complex) clinical research than ever before, regulatory writers are facing…
CertaraJune 14, 2024
Certara Recognized as a Top Biopharma Workplace for 2024
RADNOR, PA – June 12, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraJune 12, 2024
How QSP Brings Insights and Accelerates Bispecific Antibody Drug Development [China Webinar]
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…
CertaraJune 7, 2024
